Literature DB >> 334345

A cheap oral therapy for Paget's disease of bone.

R A Evans.   

Abstract

Mesh:

Substances:

Year:  1977        PMID: 334345     DOI: 10.1007/bf02064081

Source DB:  PubMed          Journal:  Calcif Tissue Res        ISSN: 0008-0594


× No keyword cloud information.
  6 in total

1.  Actinomycin D in the treatment of Paget's disease of bone.

Authors:  P J Somerville; R A Evans
Journal:  Med J Aust       Date:  1975-07-05       Impact factor: 7.738

Review 2.  The cellular basis of metabolic bone disease.

Authors:  H Rasmussen; P Bordier
Journal:  N Engl J Med       Date:  1973-07-05       Impact factor: 91.245

3.  Hypoparathyroidism and Paget's disease: the effect of parathyroid hormone administration.

Authors:  S M Genuth; L Klein
Journal:  J Clin Endocrinol Metab       Date:  1972-11       Impact factor: 5.958

Review 4.  Skeletal renewal and metabolic bone disease.

Authors:  W H Harris; R P Heaney
Journal:  N Engl J Med       Date:  1969-01-30       Impact factor: 91.245

5.  Influence of disodium etidronate on clinical and laboratory manifestations of Paget's disease of bone (osteitis deformans).

Authors:  R D Altman; C C Johnston; M R Khairi; H Wellman; A N Serafini; R R Sankey
Journal:  N Engl J Med       Date:  1973-12-27       Impact factor: 91.245

6.  The clinical and metabolic effects of porcine calcitonin on Paget's disease of bone.

Authors:  F Shai; R K Baker; S Wallach
Journal:  J Clin Invest       Date:  1971-09       Impact factor: 14.808

  6 in total
  2 in total

1.  Medical staff conference. Paget disease of bone.

Authors: 
Journal:  West J Med       Date:  1978-09

2.  The treatment of metabolic bone disease.

Authors:  S Posen; P Clifton-Bligh; R S Mason
Journal:  Drugs       Date:  1979-04       Impact factor: 9.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.